New steps in infliximab therapeutic drug monitoring in patients with inflammatory bowel diseases.

Benjamin NemozDavid TernantSébastien BaillyElodie Gautier-VeyretJean-François JourdilBruno BonazFrançoise Stanke-Labesque

Published in: British journal of clinical pharmacology (2019)

Liquid chromatography-tandem mass spectrometry measurement of IFX Cmin and the determination of a new threshold of IFX Cmin associated with biological remission are new steps towards IFX treatment personalization in patients with IBD.

Keyphrases

liquid chromatography tandem mass spectrometry
solid phase extraction
ulcerative colitis
simultaneous determination
ms ms
molecularly imprinted
tandem mass spectrometry
disease activity
liquid chromatography
systemic lupus erythematosus
mass spectrometry
replacement therapy